Pharmaceutical company Mylan NV (Nasdaq:MYL)(TASE:MYL) said on Friday that the shareholders of Meda
Aktiebolag (publ.) will tender all their shares in Mylan under the recommended public offer.
The total value of the offer for all Meda
shares, including Meda
net debt, is approximately SEK 83.6bn or USD 9.9bn, which represents a multiple of approximately 8.9x 2015 adjusted EBITDA with synergies.
is a unique and strategic asset, with a high-quality workforce, which will add to our powerful, diversified and sustainable global platform," Mylan executive chairman Robert Coury said in a statement.
According to Meda
, this nomination committee has been appointed as per the specifications of its 2015b annual general meeting.
Jeff Cohen: Meda
AB is a $1.7 billion international specialty pharmaceutical company focused on allergy/asthma, pain management, dermatology and specialty OTC products.
"This is by far Meda
's largest product and one of the products that's actually showing growth," Jenni Routtinen, an analyst at ABG Sundal Collier, said.
The settlement agreement allows Apotex to launch a generic version of Astelin[R], under a license from Meda
, on 1 March 2010.
Information about environmental schemes funded under SMAP and other MEDA
and EU programmes is available on a special Internet portal launched on June 16.
The former MEDA
countries Cyprus and Malta will bring an EU influence to bear on the economic area in terms of the exploitation of the Mediterranean's marine resources.
M2 EQUITYBITES-August 8, 2016-Mylan Closes USD 7.2bn Acquisition of Swedish Drugmaker Meda